Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Richard W Joseph,Jeroen Elassaiss-Schaap,Richard Kefford,Wen-Jen Hwu,Jedd D Wolchok,Anthony M Joshua,Antoni Ribas,F Stephen Hodi,Omid Hamid,Caroline Robert,Adil Daud,Roxana Dronca,Peter Hersey,Jeffrey S Weber,Amita Patnaik,Dinesh P de Alwis,Andrea Perrone,Jin Zhang,S Peter Kang,Scot Ebbinghaus,Keaven M Anderson,Tara C Gangadhar CLINICAL CANCER RESEARCH（2018）
AI 理解论文
溯源树
样例
